Just a decade ago, detecting amyloid plaques in the brain—a defining trait of Alzheimer's disease—required a post-mortem examination. Today, with advancements in medical imaging, radiologists can use PET amyloid imaging to see these plaques in living patients, sometimes before symptoms even appear. 🧠 By using an F18 radiotracer, PET scans can help clinicians make early diagnoses, assess treatment impact, and gain a better understanding of disease progression. This powerful procedure can provide